COVID encephalitis resulting in focal seizures with
subsequent changes on MRI Imaging
Adena

1
Shahinian ,

1
Ferreira ,

1
Lim ,

1
Robinson ,

1
Chopra ,

1
Mehta ,

Aleksandra
Chee
Gina
Jasmine
Trusha
4
1,3
1,2
1,2
Raveena Bakhru , Syed Akbarullah , Aroucha Vickers , Paul Janda
1
2
3
Valley Hospital Medical Center , Las Vegas Neurology Center , Pulmonary Associates , Touro University
4
Nevada

INTRODUCTION

HOSPITAL COURSE

CONCLUSION

The neurologic manifestations associated with COVID-19 infection have been
demonstrating increased clinical prevalence, with a presumed route of entry through
the olfactory bulb leading to inflammation and demyelination Narula, Zombori. Of the
common neurologic sequelae, seizures associated with SARS-COV have rarely been
reported, and are hypothesized to occur as a result of acute systemic illness Zombori.
Seizures with associated diffusion weight imaging (DWI) restriction on MRI are an
accepted consequence after a single seizure episode Hübers. The associated DWI
restrictions often appear as a hyperintense signal involving the cerebral cortex or
hippocampi with corresponding hypointensity on apparent diffusion coefficient (ADC)
images Pai. The pattern typically resembles a ribbon alongside the cortical band or
around the border of a defined lesion Asadi-Pooya. Restriction is also often associated with
gyral/cortical swelling and T2/FLAIR hyperintensity Pai. It is believed that these peri-ictal
DWI and T2/FLAIR abnormalities likely reflect cytotoxic and vasogenic edema as a
result of the increased blood flow and metabolic rate induced by seizure activity in the
brain Pai. We present a rare case of COVID-19 encephalitis that resulted in focal seizures
with associated post-ictal changes on MRI imaging, which to our knowledge has rarely
been reported in the literature.

We present a 52-year-old, right-handed Caucasian female, with a past medical history significant for relapsing
remitting multiple sclerosis (RRMS), chronic bilateral lower extremity paraparesis, who presented secondary to focal
seizure activity involving her left upper extremity and face with associated left sided gaze preference with associated
changes in mentation for approximately 3 weeks prior to admission. Patient was diagnosed with RRMS in 2010, had
been on a several disease modifying medications including Glatiramer Acetate initially, followed by Fingolimod, which
she did not tolerate. She has just been prescribed Ocrelizumab prior to admission but was not able to start prior to this
admission.

Since the onset of COVID-19, the neurologic sequelae of this primarily presumed respiratory
illness are beginning to unfold, and are becoming more prevalent Narula. Neurologic manifestations
of COVID-19 have been reported to be present in about 25% of patients, with a wide spectrum of
symptoms ranging from dizziness, seizures, strokes to impaired consciousness Asadi-Pooya. Seizures in
association with COVID-19 encephalitis have become more accepted, and are thought to be
related to acute systemic illness Asadi-Pooya. Numerous case studies have reported
electroencephalogram (EEG) findings in patients with COVID-19 encephalitis that are consistent
with focal areas of status epilepticus especially in the temporal, fronto-temporal, and centroparietal regions Narula. It is an accepted consequence that epileptiform discharges especially status
epilepticus have associated DWI alterations on MRI imaging Hübers.

Upon evaluation by the neurology service, patient was noted to be obtunded and unresponsive. She had an initial
CT head without contrast performed which demonstrated a large wedge-shaped area of low attenuation in the right
frontal lobe initially concerning for possible subacute infarct. Patient has also been found to be COVID-19 positive at
this time, for which she was treated in the ICU. Initial MRI Brain with and without contrast revealed right frontal
restricted diffusion, diffuse brain degenerative changes, bilateral white matter T2/FLAIR hyperintense foci without
abnormal enhancement post IV contrast administration, no intracranial abnormal enhancement (Image 1). Further
imaging studies including MRA head without contrast, MRV head without contrast, Carotid ultrasound, CTA of the head
and neck with and without contrast were all unremarkable. MRI Cervical and Thoracic spine were performed, showing
multilevel cord signal abnormalities compatible with patient’s history of RRMS, no enhancing lesions were noted. She
had an extensive workup including a lumbar puncture which was unremarkable except for a lymphocyte predominant
pleocytosis, CSF studies for COVID-19 were not available in our facility.
Several initial EEGs were negative for epileptiform discharges, but significant for mild to moderate bihemispheric
slowing. After several days of hospitalization, EEG was notable for epileptiform discharges originating from the right
frontal lobe. Patient was treated with multiple antiseizure medications with eventual resolution of epileptiform
discharges and seizure activity. MRI Brain with and without contrast was repeated21 days after the initial MRI and it
demonstrated resolution of previously seen restricted diffusion and T2 hyperintensity in the right frontal cortex (Image
2). Patient’s clinical state significantly improved and patient was discharged home with close follow up.

Imaging

As seen in this case presentation, the patient was noted to have right frontal epileptiform
discharges on her electroencephalogram (EEG), that correlated with the cortical ribboning and
restriction of diffusion seen in the right frontal lobe on MRI imaging, DWI sequence. It is presumed
that the focal seizures in our patient were provoked by COVID -19 encephalitis that eventually led
to the presence of MRI changes consistent with post-ictal changes; a well-known and accepted
sequela of focal seizures. We do also raise the possibility that the COVID-19 encephalitis may have
led to cortical MRI changes that may have resulted in focal seizures with associated epileptiform
discharges. There have been rare case reports that do demonstrate cortical changes that have
then been associated with late-onset seizures Zombori. Though the latter seems less likely in our
case presentation as the DWI changes in the right frontal region on MRI imaging resolved with the
treatment of the continuous seizure activity. It is important to recognize seizure and associated
MRI changes as a potential sequela of COVID-19 encephalitis since urgent treatment of seizures
are known to improve morbidity and mortality. It is also important to consider post-ictal changes
on the differential diagnosis for DWI changes on MRI imaging as there is a broad differential of
diagnoses may restrict diffusion on MRI imaging and it is important to diagnose appropriately,
correlate clinically in order to ensure the patient is treated appropriately.
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Image 1: Initial MRI Brain with and without contrast, demonstrating an axial DWI image (on the left)
showing restriction of diffusion in the right frontal lobe, with the associated ADC image (on the right) that
demonstrates drop-out.

Image 2: This is the repeat MRI brain done 21 days after the initial MRI brain, after
treatment of patient’s focal seizures. demonstrated the resolution of the right frontal DWI
restriction (on the left) with resolution of ADC (on the right) drop-out.
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